BDMD Baird Medical Investment Holdings Limited logo

BDMD Baird Medical Investment Holdings Limited

Healthcare
$1.63-0.61%ClosedMarket Cap: $66.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

6.93

PEG

P/B

1.50

P/S

2.96

EV/EBITDA

-3.55

DCF Value

$2.51

FCF Yield

-2.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

83.8%

Operating Margin

-113.7%

Net Margin

-121.0%

ROE

-81.5%

ROA

-39.1%

ROIC

-50.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$14.6M$-16.0M$
FY null$22.5M$-27.3M$
Q2 null$8.0M$-11.3M$
Q4 null$23.9M$8.1M$

Trading Activity

Insider Trades

View All
Xu Lijiandirector
SellTue Apr 21
Qiu Quandirector:
SellTue Apr 21
Lu Rongjianofficer
SellTue Apr 21
Bilciu-Wolfson Gabrielledirector
SellFri Apr 17
Li Jie Claraofficer
SellWed Apr 15

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

CN

Exchange

Beta

-1.19

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Peers